Evidence map›Paper›PMID 31731697›Full record

ArticleMarine drugs2019

Novel Microcystins from

Vittoria Mallia, Silvio Uhlig, Cheryl Rafuse, Juris Meija, Christopher O Miles

Open access · goldAbstract read
In one paragraph

Article in Marine drugs, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Preparation ofAnalytical and bioanalytical chemistry · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Production and stability of Oxygen-18 labeled Caribbean ciguatoxins and gambierones.Toxicon : official journal of the International Society on Toxinology · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Vittoria MalliaToxinology Research Group, Norwegian Veterinary Institute, Ullevålsveien 68, N-0454 Oslo, Norway.
Silvio UhligToxinology Research Group, Norwegian Veterinary Institute, Ullevålsveien 68, N-0454 Oslo, Norway.ORCID 0000-0001-6419-9563
Cheryl RafuseNational Research Council, 1411 Oxford Street, Halifax, NS B3H 3Z1, Canada.
Juris MeijaNational Research Council, 1200 Montreal Road, Ottawa, ON K1A 0R6, Canada.
Christopher O MilesNational Research Council, 1411 Oxford Street, Halifax, NS B3H 3Z1, Canada.
National Research Council Canada · CANorwegian Veterinary Institute · NOUniversity of Oslo · NO

Funding

European Union's Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement 722634
6 · The paper itself

Abstract

Microcystins are cyclic heptapeptides from cyanobacteria that are potent inhibitors of protein phosphatases and are toxic to animals and humans. At present, more than 250 microcystin variants are known, with variants reported for all seven peptide moieties. While d-glutamic acid (d-Glu) is highly-conserved at position-6 of microcystins, there has been only one report of a cyanobacterium (

Indexed as

AnabaenaBacterial ToxinsChromatography, LiquidCyanobacteriaMicrocystinsNitrogenNitrogen IsotopesOxidation-ReductionPlanktothrixSulfhydryl CompoundsSulfidesTandem Mass SpectrometryBacterial ToxinsMicrocystinsNitrogenNitrogen IsotopesSulfhydryl CompoundsSulfidescyanotoxinhepatotoxinmass spectrometrymicrocystinPlanktothrix

Identifiers

PMID31731697
PMCPMC6891653
OpenAlexW2988039790

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.